Cargando…
Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191677/ http://dx.doi.org/10.1186/1546-0096-12-S1-P339 |
| _version_ | 1782338706613469184 |
|---|---|
| author | Roca, Clara Giménez Iglesias, Estíbaliz Bou, Rosa Torrente-Segarra, Vicente Sánchez-Manubens, Judith Calzada-Hernández, Joan Hernández, Samuel Ricart, Sílvia Antón, Jordi |
| author_facet | Roca, Clara Giménez Iglesias, Estíbaliz Bou, Rosa Torrente-Segarra, Vicente Sánchez-Manubens, Judith Calzada-Hernández, Joan Hernández, Samuel Ricart, Sílvia Antón, Jordi |
| author_sort | Roca, Clara Giménez |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4191677 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-41916772014-11-05 Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age Roca, Clara Giménez Iglesias, Estíbaliz Bou, Rosa Torrente-Segarra, Vicente Sánchez-Manubens, Judith Calzada-Hernández, Joan Hernández, Samuel Ricart, Sílvia Antón, Jordi Pediatr Rheumatol Online J Poster Presentation BioMed Central 2014-09-17 /pmc/articles/PMC4191677/ http://dx.doi.org/10.1186/1546-0096-12-S1-P339 Text en Copyright © 2014 Roca et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Roca, Clara Giménez Iglesias, Estíbaliz Bou, Rosa Torrente-Segarra, Vicente Sánchez-Manubens, Judith Calzada-Hernández, Joan Hernández, Samuel Ricart, Sílvia Antón, Jordi Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age |
| title | Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age |
| title_full | Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age |
| title_fullStr | Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age |
| title_full_unstemmed | Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age |
| title_short | Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age |
| title_sort | efficacy and safety of tnf-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191677/ http://dx.doi.org/10.1186/1546-0096-12-S1-P339 |
| work_keys_str_mv | AT rocaclaragimenez efficacyandsafetyoftnfalphaantagonistsinchildrenwithjuvenileidiopathicarthritiswhostartedtreatmentunder4yearsofage AT iglesiasestibaliz efficacyandsafetyoftnfalphaantagonistsinchildrenwithjuvenileidiopathicarthritiswhostartedtreatmentunder4yearsofage AT bourosa efficacyandsafetyoftnfalphaantagonistsinchildrenwithjuvenileidiopathicarthritiswhostartedtreatmentunder4yearsofage AT torrentesegarravicente efficacyandsafetyoftnfalphaantagonistsinchildrenwithjuvenileidiopathicarthritiswhostartedtreatmentunder4yearsofage AT sanchezmanubensjudith efficacyandsafetyoftnfalphaantagonistsinchildrenwithjuvenileidiopathicarthritiswhostartedtreatmentunder4yearsofage AT calzadahernandezjoan efficacyandsafetyoftnfalphaantagonistsinchildrenwithjuvenileidiopathicarthritiswhostartedtreatmentunder4yearsofage AT hernandezsamuel efficacyandsafetyoftnfalphaantagonistsinchildrenwithjuvenileidiopathicarthritiswhostartedtreatmentunder4yearsofage AT ricartsilvia efficacyandsafetyoftnfalphaantagonistsinchildrenwithjuvenileidiopathicarthritiswhostartedtreatmentunder4yearsofage AT antonjordi efficacyandsafetyoftnfalphaantagonistsinchildrenwithjuvenileidiopathicarthritiswhostartedtreatmentunder4yearsofage |